Clinical trial Recruiting at 1 site Interventional Ages 50 and up

Blood Flow Restriction Walking for stroke-related sarcopenia

Official title: Effects of Blood Flow Restriction Training on Physical Performance in Individuals With Stroke-Related Sarcopenia: A Randomized Controlled Trial

Run by The Hong Kong Polytechnic University · NCT06974461 · Data updated 2026-11-12

This study tests whether walking with blood flow restriction helps improve muscle strength and physical function in people who had a chronic stroke and have sarcopenia.

Quick facts

Study typeInterventional
Ages50 Years and up
SexAll
Enrollment64 (estimated)
SponsorThe Hong Kong Polytechnic University
Academic / other
Locations2 sites (Hung Hom, Kowloon and 1 other locations)
StatusRecruiting
StartedSeptember 1, 2025
Main results expectedDecember 28, 2027
Study endsDecember 28, 2027
Registry record updatedAugust 24, 2026
Trial IDNCT06974461 on ClinicalTrials.gov

Is this trial a fit for you?

Likely a good fit

Adults with chronic stroke (≥6 months) who meet AWGS 2025 criteria for sarcopenia.

Probably not a fit

Patients without sarcopenia or those unable to tolerate BFR may not benefit.

A plain-English reading of the study's rules. Only the study team can confirm whether you qualify.

What this trial studies

In this randomized, sham-controlled trial, chronic stroke patients with sarcopenia will perform walking with blood flow restriction or a sham version to see if the intervention improves muscle strength and physical performance. Secondary outcomes will explore possible changes in muscle mass, vascular function, and quality of life. Eligibility requires chronic stroke status and sarcopenia defined by AWGS 2025 criteria. The Hong Kong Polytechnic University leads the trial in Hong Kong.

Why it matters

Potential benefit: If successful, patients may experience greater gains in strength and function from a low‑impact walking approach.

How similar studies have gone: Previous studies in related populations have shown signal of benefit with BFR approaches, but this exact protocol in chronic stroke with sarcopenia is novel.

Who can join: the full rules

Show full inclusion / exclusion criteria
Inclusion Criteria:

* Diagnosed with chronic stroke (≥6 months post-stroke)
* Sarcopenia will be diagnosed using the Asian Working Group for Sarcopenia (AWGS) 2025 criteria, defined as the concurrent presence of low muscle strength and low appendicular skeletal muscle mass. Muscle strength will be assessed using handgrip strength measured on the non-paretic side. Low muscle strength will be defined as handgrip strength \<28 kg for men and \<18 kg for women aged ≥65 years, and \<34 kg for men and \<20 kg for women aged 50-64 years. Appendicular skeletal muscle mass will be measured using bioelectrical impedance analysis, and the appendicular skeletal muscle mass index will be calculated as appendicular skeletal muscle mass divided by height squared. Low muscle mass will be defined as an appendicular skeletal muscle mass index \<7.0 kg/m² for men and \<5.7 kg/m² for women aged ≥65 years, and \<7.6 kg/m² for men and \<5.7 kg/m² for women aged 50-64 years.

Exclusion Criteria:

* Stroke occurred within the past 6 months
* Resting systolic blood pressure \> 200 mmHg
* Resting diastolic blood pressure \> 100 mmHg
* Presence of implanted electronic or metallic devices that interfere with blood flow restriction cuffs
* Contraindication to bioelectrical impedance analysis (e.g., pacemaker, ICD)

Where it's running

  • Hong Kong Polytechnic University
    Hung Hom, Kowloon, Hong Kong
    Recruiting
  • Hong Kong Polytechnic University
    Hung Hom, Kowloon, Hong Kong
    Not yet recruiting

Study contacts

Similar studies

Other studies for the same condition or treatment. Recruiting studies are listed first.

How to take part

  1. Review the eligibility criteria above with your treating physician.
  2. Check the official listing on ClinicalTrials.gov for the latest contact details and recruitment status.
  3. Contact the study coordinator or principal investigator to ask for pre-screening. Pre-screening is free and never obligates you to enroll.
Last reviewed 2026-11-14 by the Find a Trial editorial team. Information on this page is for educational purposes and is not medical advice. Always consult qualified healthcare professionals about clinical trial participation.